Biomapas CRO Opens New Office in Lausanne, Switzerland
Switzerland (PRWEB) December 07, 2015 -- Biomapas CRO is pleased to announce the opening of its new Swiss office in Lausanne, Switzerland. The new office strengthens the company’s presence in Western Europe and further boosts its growth and expansion. The Swiss office will offer business development support for all countries in Europe.
Claire Martin, the Managing Director at Biomapas Sarl, will head the new office. Claire has 20 years’ experience in the clinical research, and has worked as a clinical scientist for more than 10 years in Europe. “This strategic location at the Biopole, Lausanne, Switzerland positions Biomapas to add greater value to our growing customer base in Europe,” said Claire.
”Our aim is also to increase our client base with Swiss and Western European life science companies. Especially in Switzerland there are a large number of innovative biotech companies and a well-functioning pharma market. Local companies are well established to bring their products to market or drug candidates through clinical development. We see a great potential for collaboration,” concludes Audrius Sveikata, CEO of Biomapas.
Biomapas, is a leader in the Eastern European market in clinical research services. Biomapas provides extensive support, from clinical trials, regulatory affairs and pharmacovigilance services. This enables to support Biomapas business partners’ journey from clinical development to marketing authorization and post-authorization support.
The Biomapas team ensures quality services for each customer, from small biotechnology companies, Medtechs, regional affiliates, to Top Global Pharma companies, and CROs. Biomapas offers multiple solutions for partners, including a full service approach, covering services from clinical development to post-authorization support. Biomapas expertise incorporates scientific and medical knowledge and extensive experience in clinical, pharmaceutical and biotech fields in order to ensure integrative, tailor-made solutions for our clients.
About Biomapas:
BIOMAPAS CRO is a team of experts, specializing in Phase I-IV clinical trials monitoring and project management; Regulatory Affairs, Marketing Authorization Approvals, and Pharmacovigilance services. Biomapas has more than 15 years of experience, playing a bridging role between the West and East of Europe. Biomapas supports companies in EU and Eastern European markets, such as Russia, Ukraine, Belarus, and Georgia.
Biomapas is certified to be in compliance with ISO 9001 standards.
Therapeutic expertise: CNS, cardiovascular, oncology, neurology, rheumatology, endocrinology, respiratory, gastrointestinal.
Services: Clinical Trial Management and Monitoring, Project Management, Site Management, Post-Marketing Studies, Clinical Safety, QA, Data Management, Regulatory Affairs, Pre-submission Assessment and Consulting, Marketing Authorization Application and submission, Package Leaflet Readability Testing, Medical Writing, Electronic Submission, Pharmacovigilance, GCP Training, Full-service CRO.
For more information, please contact:
Claire Martin Leroy, MSc, Director Biomapas Switzerland +41 78 7340191
Audrius Sveikata, M.D., Ph.D., Managing Director Biomapas +370 3736 6307
info(at)biomapas.eu
To learn more about Biomapas, please visit http://www.biomapas.eu
Source: Biomapas
Claire Martin Leroy, Biomapas, http://www.biomapas.eu/, +370 37366307, [email protected]
Share this article